• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4831755)   Today's Articles (5682)
For: Van Holten RW, Autenrieth SM. Evaluation of depth filtration to remove prion challenge from an immune globulin preparation. Vox Sang 2003;85:20-4. [PMID: 12823726 DOI: 10.1046/j.1423-0410.2003.00312.x] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Number Cited by Other Article(s)
1
O'Mara B, Singh NK, Menendez A, Tipton B, Vail A, Voloshin A, Buechler Y, Anderson SM. Single-stage chromatographic clarification of Chinese Hamster Ovary cell harvest reduces cost of protein production. Biotechnol Prog 2023;39:e3323. [PMID: 36598038 DOI: 10.1002/btpr.3323] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2022] [Revised: 12/08/2022] [Accepted: 01/03/2023] [Indexed: 01/05/2023]
2
Khanal O, Singh N, Traylor SJ, Xu X, Ghose S, Li ZJ, Lenhoff AM. Contributions of depth filter components to protein adsorption in bioprocessing. Biotechnol Bioeng 2018;115:1938-1948. [DOI: 10.1002/bit.26707] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2018] [Revised: 02/28/2018] [Accepted: 04/06/2018] [Indexed: 01/18/2023]
3
Bett C, Grgac K, Long D, Karfunkle M, Keire DA, Asher DM, Gregori L. A Heparin Purification Process Removes Spiked Transmissible Spongiform Encephalopathy Agent. AAPS JOURNAL 2017;19:765-771. [DOI: 10.1208/s12248-017-0047-y] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/15/2016] [Accepted: 01/11/2017] [Indexed: 02/08/2023]
4
Chou ML, Bailey A, Avory T, Tanimoto J, Burnouf T. Removal of transmissible spongiform encephalopathy prion from large volumes of cell culture media supplemented with fetal bovine serum by using hollow fiber anion-exchange membrane chromatography. PLoS One 2015;10:e0122300. [PMID: 25874629 PMCID: PMC4395333 DOI: 10.1371/journal.pone.0122300] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/24/2014] [Accepted: 02/19/2015] [Indexed: 11/19/2022]  Open
5
Cai K, Gröner A, Dichtelmüller HO, Fabbrizzi F, Flechsig E, Gajardo R, von Hoegen I, Jorquera JI, Kempf C, Kreil TR, Lee DC, Moscardini M, Pölsler G, Roth NJ. Prion removal capacity of plasma protein manufacturing processes. Transfusion 2012;53:1894-905. [DOI: 10.1111/trf.12050] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2012] [Revised: 10/09/2012] [Accepted: 10/13/2012] [Indexed: 01/06/2023]
6
Roberts PL, Dalton J, Evans D, Harrison P, Li Z, Ternouth K, Thirunavukkarasu V, Bulmer M, Fernando S, McLeod N. Removal of TSE agent from plasma products manufactured in the United Kingdom. Vox Sang 2012;104:299-308. [PMID: 23170907 DOI: 10.1111/vox.12004] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
7
Bannach O, Birkmann E, Reinartz E, Jaeger KE, Langeveld JPM, Rohwer RG, Gregori L, Terry LA, Willbold D, Riesner D. Detection of prion protein particles in blood plasma of scrapie infected sheep. PLoS One 2012;7:e36620. [PMID: 22567169 PMCID: PMC3342177 DOI: 10.1371/journal.pone.0036620] [Citation(s) in RCA: 30] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2012] [Accepted: 04/03/2012] [Indexed: 01/12/2023]  Open
8
Diez JM, Caballero S, Belda F, Otegui M, Gajardo R, Jorquera JI. Capacity of the manufacturing process of Flebogamma® DIF, a new human high purity intravenous immunoglobulin, to remove a TSE model-agent. Biologicals 2010;38:670-4. [DOI: 10.1016/j.biologicals.2010.08.003] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2010] [Revised: 07/16/2010] [Accepted: 08/19/2010] [Indexed: 11/29/2022]  Open
9
Liu HF, Ma J, Winter C, Bayer R. Recovery and purification process development for monoclonal antibody production. MAbs 2010;2:480-99. [PMID: 20647768 DOI: 10.4161/mabs.2.5.12645] [Citation(s) in RCA: 343] [Impact Index Per Article: 22.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]  Open
10
Removal of TSE agents by depth or membrane filtration from plasma products. Biologicals 2010;38:158-61. [DOI: 10.1016/j.biologicals.2009.09.004] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2009] [Revised: 08/27/2009] [Accepted: 09/21/2009] [Indexed: 11/24/2022]  Open
11
Seeger H, Julius C, Cozzari C, Calella AM, Dattilo M, Aguzzi A. Prion depletion and preservation of biological activity by preparative chaotrope ultracentrifugation. Biologicals 2008;36:403-11. [PMID: 18760936 DOI: 10.1016/j.biologicals.2008.07.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/18/2007] [Revised: 06/26/2008] [Accepted: 07/16/2008] [Indexed: 10/21/2022]  Open
12
Svae TE, Neisser-Svae A, Bailey A, Reichl H, Biesert L, Schmidt T, Heger A, Römisch J. Prion safety of transfusion plasma and plasma-derivatives typically used for prophylactic treatment. Transfus Apher Sci 2008;39:59-67. [DOI: 10.1016/j.transci.2008.05.006] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
13
Poelsler G, Berting A, Kindermann J, Spruth M, Hämmerle T, Teschner W, Schwarz HP, Kreil TR. A new liquid intravenous immunoglobulin with three dedicated virus reduction steps: virus and prion reduction capacity. Vox Sang 2008;94:184-192. [PMID: 18167162 DOI: 10.1111/j.1423-0410.2007.01016.x] [Citation(s) in RCA: 36] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
14
Seitz R, von Auer F, Blümel J, Burger R, Buschmann A, Dietz K, Heiden M, Hitzler WE, Klamm H, Kreil T, Kretzschmar H, Nübling M, Offergeld R, Pauli G, Schottstedt V, Volkers P, Zerr I. Impact of vCJD on blood supply. Biologicals 2007;35:79-97. [PMID: 17320412 DOI: 10.1016/j.biologicals.2007.01.002] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2006] [Revised: 01/09/2007] [Accepted: 01/09/2007] [Indexed: 10/23/2022]  Open
15
Kempf C, Stucki M, Boschetti N. Pathogen inactivation and removal procedures used in the production of intravenous immunoglobulins. Biologicals 2007;35:35-42. [PMID: 16581263 PMCID: PMC7129354 DOI: 10.1016/j.biologicals.2006.01.002] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2005] [Revised: 11/11/2005] [Accepted: 01/16/2006] [Indexed: 11/17/2022]  Open
16
Burnouf T, Padilla A. Current strategies to prevent transmission of prions by human plasma derivatives. Transfus Clin Biol 2007;13:320-8. [PMID: 17254822 DOI: 10.1016/j.tracli.2006.11.001] [Citation(s) in RCA: 36] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
17
Thyer J, Unal A, Thomas P, Eaton B, Bhashyam R, Ortenburg J, Uren E, Middleton D, Selleck P, Maher D. Prion-removal capacity of chromatographic and ethanol precipitation steps used in the production of albumin and immunoglobulins. Vox Sang 2006;91:292-300. [PMID: 17105604 DOI: 10.1111/j.1423-0410.2006.00829.x] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
18
Yunoki M, Urayama T, Ikuta K. Possible removal of prion agents from blood products during the manufacturing process. Future Virol 2006. [DOI: 10.2217/17460794.1.5.659] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
19
Burdick MD, Pifat DY, Petteway SR, Cai K. Clearance of prions during plasma protein manufacture. Transfus Med Rev 2006;20:57-62. [PMID: 16373188 DOI: 10.1016/j.tmrv.2005.08.005] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
20
Wang K, Johnson A, Obradovic M, Anderson G, Maclean C, Nair H. TSE clearance during plasma products separation process by Gradiflow™. Biologicals 2005;33:87-94. [PMID: 15939286 DOI: 10.1016/j.biologicals.2005.01.002] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/24/2004] [Revised: 01/13/2005] [Accepted: 01/19/2005] [Indexed: 10/25/2022]  Open
21
Hartwell RC, Nelson MS, Kislan MM, Stenland CJ, Miller JLC, Pifat DY, Petteway SR, Cai K. An improved Western blot assay to assess the clearance of prion protein from plasma-derived therapeutic proteins. J Virol Methods 2005;125:187-93. [PMID: 15794989 DOI: 10.1016/j.jviromet.2005.01.026] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/12/2004] [Revised: 01/17/2005] [Accepted: 01/18/2005] [Indexed: 11/26/2022]
22
Foster PR, Griffin BD, Bienek C, McIntosh RV, MacGregor IR, Somerville RA, Steele PJ, Reichl HE. Distribution of a bovine spongiform encephalopathy-derived agent over ion-exchange chromatography used in the preparation of concentrates of fibrinogen and factor VIII. Vox Sang 2004;86:92-9. [PMID: 15023177 DOI: 10.1111/j.0042-9007.2004.00403.x] [Citation(s) in RCA: 30] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
23
Foster PR. Removal of TSE agents from blood products. Vox Sang 2004;87 Suppl 2:7-10. [PMID: 15209867 DOI: 10.1111/j.1741-6892.2004.00444.x] [Citation(s) in RCA: 40] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA